eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

sanofi-aventis
1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 07/12/2011
PIL Telfast 180mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 10/01/2011 and displayed until 07/12/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 07/05/2009 and displayed until 10/01/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 12/12/2008 and displayed until 07/05/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 19/09/2007 and displayed until 12/12/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 22/08/2003 and displayed until 19/09/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 24/10/2001 and displayed until 22/08/2003
Reasons for adding or updating:
  • Update to PIL

Active Ingredients/Generics

 
  fexofenadine hydrochloride